Evonik's Buyout Hopes Fade to a 24-Euro Hurdle as RAG-Stiftung Keeps Its Own Timetable
Published on 11/21/2026 at 13:51 | Editorial boerse-global.deBASF's decision to walk away from Evonik this week has left the specialty chemicals maker trading below the last price its suitor was willing to pay — a gap that reflects the absence of any live offer rather than a fresh takeover premium in waiting. Evonik shares closed yesterday at €18.18 following Thursday's slide, well under the €24 per share BASF had floated in its final, non-binding cash proposal.
That proposal, tabled on 22 October, valued the company at roughly €11.2 billion and represented an increase on BASF's initial September approach of €22.15 per Evonik share. Evonik's management board rejected the raised offer on 30 October, sticking with its standalone course — the second rebuff in the process. Neither bid was ever binding.
What It Would Take to Restart Talks
Bernstein analyst James Hooper sees a path back to the negotiating table, but a narrow one. In comments reported yesterday, he argued Evonik would have to approach BASF first and make the case that it is worth more than €24 a share. That is a description of the conditions for talks, not a forecast of a renewed bid.
The price alone would not be enough. BASF said its withdrawal this week was also down to being denied access to a deeper round of due diligence. Interim Evonik chief Claus Rettig, meanwhile, intends to press ahead with the group's independent growth strategy.
Should investors sell immediately? Or is it worth buying Evonik?
BASF has framed its restraint around capital discipline and returns for its own shareholders, arguing that a higher price could not be justified given the risks and business outlook Evonik faces on its own. The €24 figure therefore marks what BASF was prepared to pay during its pursuit — not an agreed sale price for any stake.
The Anchor Shareholder's Separate Agenda
Evonik's largest investor, RAG-Stiftung, confirmed yesterday that it still intends to cut its holding to 25.1% over the long term, though it gave no timetable. The foundation, which is building up other capital investments to fund the legacy costs of hard-coal mining, expressed regret that BASF did not stay in the hunt longer and that no deeper talks between the two management boards materialised. Neither sentiment amounts to backing a sale on the terms on offer.
The timing of any selldown remains an open question, and the target gives direction rather than a schedule. Political headwinds may also have weighed on BASF's exit: the Frankfurter Allgemeine Zeitung reported that opposition from policymakers played a decisive role, with North Rhine-Westphalia premier Hendrik WĂĽst pointing to the 11,000 Evonik jobs in the state. BASF had already offered protections for sites, research and employment in Germany through 2032 in October.
Earnings Become the Yardstick
With the ownership question parked, attention turns to Evonik's operating performance as the measure of its standalone case. Adjusted EBITDA climbed 40% year on year to €629 million in the third quarter of 2026. For the full year, the company expects adjusted EBITDA in the upper half of a €2.0 billion to €2.2 billion range.
Those two threads — the foundation's long-term ownership target and Evonik's earnings guidance — address different things, and investors would do well to keep them apart. For now, Hooper's assessment reads chiefly as a map of the obstacles: the anchor shareholder's wish for deeper talks substitutes for neither Evonik's willingness to engage nor BASF's readiness to pay more.
Ad
Evonik Stock: New Analysis - 21 November
Fresh Evonik information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
